PALMISANO ROBERT J - 25 Jul 2024 SCHEDULE 13D/A Report for AEON Biopharma, Inc. Class A Common Stock (AEON)

Filing Manager
PALMISANO ROBERT J
Reporting Manager
Robert J Palmisano
Security
AEON Biopharma, Inc. Class A Common Stock
Symbol
AEON
Shares outstanding
39,736,842 shares
Disclosed Ownership
2,265,000 shares
Ownership
5.7%
Form type
SCHEDULE 13D/A
Filing time
07 Mar 2025, 16:01:43 UTC
Date of event
25 Jul 2024
SEC
View on sec.gov

Quoteable Key Fact

"PALMISANO ROBERT J disclosed 5.7% ownership in AEON Biopharma, Inc. Class A Common Stock (AEON) on 25 Jul 2024."

Quick Takeaways

  • PALMISANO ROBERT J filed SCHEDULE 13D/A for AEON Biopharma, Inc. Class A Common Stock (AEON).
  • Disclosed ownership: 5.7%.
  • Date of event: 25 Jul 2024.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 07 Mar 2025, 16:01.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Source Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Robert J Palmisano 5.7% 2,265,000 2,265,000 0 /s/ Robert J. Palmisano Robert J. Palmisano 0001138646
The Palmisano Family, LLC 5.7% 2,265,000 2,265,000 0 /s/ Robert J Palmisano Robert J Palmisano/Manager